基本信息
浏览量:13
职业迁徙
个人简介
Group Leader: Dr Ronjon Chakraverty
Introduction
The Transplantation Immunology Group is based at the Hampstead Campus and forms part of a large Immunotherapy Programme at UCL. Our research involves both pre-clinical, translational and phase I/II projects that aim to develop innovative strategies to improve the anti-tumour effects of blood and bone marrow transplantation. We work closely with the groups of Professor Hans Stauss/Dr. Emma Morris (Tumour Immunology, Cellular and Gene Therapy), and Dr. Clare Bennett (Dendritic Cell Immunotherapy), with a number of fellows or PhD students working on joint projects.
Research
Following blood or bone marrow transplantation, donor T cells that have been infused as part of the graft or given at a later time point, become activated in response to antigenic differences between the donor and the recipient. This effect can be co-opted to generate anti-tumour activity, an effect termed the ‘graft-versus-tumour’ (GVT) response. Alternatively, donor T cells may react against normal tissues, leading to graft-versus-host disease (GVHD). See figure below:
Graft-versus-host-disease
These outcomes depend upon how donor T cells recognize antigen and this, in turn is influenced by nature of the cells presenting antigen. We are interested in how distinct non-haematopoietic and haematopoietic cell populations in the recipient influence the development of donor T cell immunity after transplantation. This research offers the opportunity to develop new approaches to manipulating antigen presentation for therapeutic benefit e.g. following vaccination.
Ultimately, durable anti-tumour immunity requires that T cells with anti-tumour reactivity engraft and then persist long-term in the recipient. By exploring clinically relevant models, we are examining the mechanisms that influence the long-term survival of anti-tumour T cells such that they can provide long-term immune surveillance. An improved understanding of the pathways that regulate this property of ‘memory’ is helping us to engineer T cells that can maintain their functions over long periods.
Introduction
The Transplantation Immunology Group is based at the Hampstead Campus and forms part of a large Immunotherapy Programme at UCL. Our research involves both pre-clinical, translational and phase I/II projects that aim to develop innovative strategies to improve the anti-tumour effects of blood and bone marrow transplantation. We work closely with the groups of Professor Hans Stauss/Dr. Emma Morris (Tumour Immunology, Cellular and Gene Therapy), and Dr. Clare Bennett (Dendritic Cell Immunotherapy), with a number of fellows or PhD students working on joint projects.
Research
Following blood or bone marrow transplantation, donor T cells that have been infused as part of the graft or given at a later time point, become activated in response to antigenic differences between the donor and the recipient. This effect can be co-opted to generate anti-tumour activity, an effect termed the ‘graft-versus-tumour’ (GVT) response. Alternatively, donor T cells may react against normal tissues, leading to graft-versus-host disease (GVHD). See figure below:
Graft-versus-host-disease
These outcomes depend upon how donor T cells recognize antigen and this, in turn is influenced by nature of the cells presenting antigen. We are interested in how distinct non-haematopoietic and haematopoietic cell populations in the recipient influence the development of donor T cell immunity after transplantation. This research offers the opportunity to develop new approaches to manipulating antigen presentation for therapeutic benefit e.g. following vaccination.
Ultimately, durable anti-tumour immunity requires that T cells with anti-tumour reactivity engraft and then persist long-term in the recipient. By exploring clinically relevant models, we are examining the mechanisms that influence the long-term survival of anti-tumour T cells such that they can provide long-term immune surveillance. An improved understanding of the pathways that regulate this property of ‘memory’ is helping us to engineer T cells that can maintain their functions over long periods.
研究兴趣
论文共 210 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
Morgane Cheminant,Thomas A. Fox,Mickael Alligon,Olivier Bouaziz,Benedicte Neven,Despina Moshous,Stephane Blanche,Aurelien Guffroy,Claire Fieschi,Marion Malphettes,Nicolas Schleinitz,Antoinette Perlat,Jean-Francois Viallard,Nathalie Dhedin,Francoise Sarrot-Reynauld,Isabelle Durieu,Sebastien Humbert,Fanny Fouyssac,Vincent Barlogis,Benjamin Carpenter,Rachael Hough,Arian Laurence,Ambroise Marcais,Ronjon Chakraverty,Olivier Hermine,Alain Fischer,Siobhan O. Burns,Nizar Mahlaoui,Emma C. Morris,Felipe Suarez
BMJ openno. 6 (2023): e067790-e067790
Bloodno. Supplement 1 (2023): 654-654
Charles Craddock,David Marks,Victoria Potter,Wendy A. Ingram, Rebecca Collings,Eleni Tholouli,Rachel Protheroe, Hugh Allen, Alex Ross, Dawn Farrar,Shamyla Siddique,Rebecca Bishop,Ronjon Chakraverty
Bloodno. Supplement 1 (2023): 5097-5097
W. Ingram, R. Collings, A. Jackson,R. Protheroe,V. Potter,F. Dignan,E. Hurst,C. Crawley,P. Kottaridis,C. Gaskell,R. Chakraverty, E. Williams,R. Bishop,C. Craddock
BONE MARROW TRANSPLANTATIONno. SUPPL 1 (2022)
引用0浏览0引用
0
0
Practical Transfusion Medicinepp.543-553, (2022)
加载更多
作者统计
#Papers: 208
#Citation: 7651
H-Index: 40
G-Index: 86
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn